Cubist Systematic Strategies, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 263 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$571,564
-86.0%
14,900
-78.5%
0.00%
-81.8%
Q1 2024$4,073,101
+39.3%
69,294
+41.9%
0.02%
+15.8%
Q4 2023$2,922,964
+56.1%
48,830
-0.8%
0.02%
+35.7%
Q3 2023$1,872,367
-56.7%
49,221
+3.7%
0.01%
-51.7%
Q2 2023$4,325,337
+161.6%
47,479
+89.4%
0.03%
+190.0%
Q1 2023$1,653,551
+73.5%
25,069
+79.7%
0.01%
+100.0%
Q3 2022$953,000
+81.9%
13,951
+35.4%
0.01%
+25.0%
Q1 2022$524,000
-57.8%
10,304
-60.8%
0.00%
-66.7%
Q4 2021$1,243,000
+11.4%
26,297
-22.3%
0.01%
-14.3%
Q3 2021$1,116,000
+168.3%
33,846
+414.1%
0.01%
+180.0%
Q2 2021$416,000
-54.8%
6,584
-69.3%
0.01%
-58.3%
Q1 2021$920,000
+80.0%
21,431
+139.7%
0.01%
+71.4%
Q4 2020$511,000
-42.0%
8,942
-69.4%
0.01%
-46.2%
Q3 2020$881,000
-26.5%
29,208
-20.5%
0.01%
-38.1%
Q2 2020$1,199,000
+71.3%
36,721
+40.6%
0.02%
+10.5%
Q1 2020$700,000
-52.7%
26,124
-45.9%
0.02%
-29.6%
Q4 2019$1,480,000
+231.8%
48,329
+160.8%
0.03%
+200.0%
Q3 2019$446,000
+22200.0%
18,534
+21704.7%
0.01%
Q2 2019$2,000
-99.2%
85
-99.3%
0.00%
-100.0%
Q1 2019$246,000
-20.1%
12,603
-46.0%
0.01%
-46.7%
Q4 2018$308,00023,3510.02%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders